| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Radiation Oncology Journal Search > Browse Articles > Search



A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
Sergey Nikolaevich Novikov, Roman Vladimirovich Novikov, Yurii Olegovich Merezhko, Mariya Yurevna Gotovchikova, Nikolai Dmitrievich Ilin, Yulia Sergeevna Melnik, Sergey Vasilevich Kanaev
Radiat Oncol J. 2022;40(3):200-207.   Published online 2022 Sep 30     DOI: https://doi.org/10.3857/roj.2022.00339
                              
roj-2022-00339f1.jpgroj-2022-00339f2.jpgt2-roj-2022-00339.pngt3-roj-2022-00339.png
Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
Ángel L. Sánchez-Iglesias, Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach
Radiat Oncol J. 2022;40(3):192-199.   Published online 2022 Sep 27     DOI: https://doi.org/10.3857/roj.2022.00101
                              
roj-2022-00101f1.jpg
Clinical Investigations
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2022;40(2):111-119.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01060
                              Supplementary         Cited By 1
roj-2021-01060f1.jpgroj-2021-01060f2.jpgt2-roj-2021-01060.png
PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
Radiat Oncol J. 2022;40(1):20-28.   Published online 2022 Mar 25     DOI: https://doi.org/10.3857/roj.2021.00934
                                 Cited By 1
roj-2021-00934f1.jpgroj-2021-00934f2.jpgroj-2021-00934f3.jpgroj-2021-00934f4.jpg
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Ding Ding, Amy Hacker-Prietz, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2021;39(4):304-314.   Published online 2021 Dec 17     DOI: https://doi.org/10.3857/roj.2021.00815
                              Supplementary         Cited By 1
roj-2021-00815f1.jpgroj-2021-00815f2.jpg
Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases
Ben Man Fei Cheung, Kin Sang Lau, Victor Ho Fun Lee, To Wai Leung, Feng-Ming Spring Kong, Mai Yee Luk, Kwok Keung Yuen
Radiat Oncol J. 2021;39(4):254-264.   Published online 2021 Oct 26     DOI: https://doi.org/10.3857/roj.2021.00311
                              Supplementary      
roj-2021-00311f1.jpgroj-2021-00311f2.jpgroj-2021-00311f3.jpg
Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
Jason Liu, Colton Ladbury, Arya Amini, Scott Glaser, Jonathan Kessler, Aram Lee, Yi-Jen Chen
Radiat Oncol J. 2021;39(2):113-121.   Published online 2021 Jun 18     DOI: https://doi.org/10.3857/roj.2021.00213
                              
roj-2021-00213f1.jpgroj-2021-00213f2.jpgroj-2021-00213f3.jpgroj-2021-00213f4.jpg
Prospective evaluation of fiducial marker placement quality and toxicity in liver CyberKnife stereotactic body radiotherapy
Debnarayan Dutta, Kaushik Jagannath Kataki, Shibu George, Sruthi K. Reddy, Ajay Sashidharan, Rajesh Kannan, Ram Madhavan, Haridas Nair, Tushar Tatineni, Raghavendra Holla
Radiat Oncol J. 2020;38(4):253-261.   Published online 2020 Nov 30     DOI: https://doi.org/10.3857/roj.2020.00472
                                 Cited By 2
roj-2020-00472f1.jpgt1-roj-2020-00472.png
Clinical Investigationses
Maximum standardized uptake value at pre-treatment PET in estimating lung cancer progression after stereotactic body radiotherapy
Jisun Park, Yunseon Choi, Ki Jung Ahn, Sung Kwang Park, Heunglae Cho, Ji Young Lee
Radiat Oncol J. 2019;37(1):30-36.   Published online 2019 Mar 31     DOI: https://doi.org/10.3857/roj.2019.00010
                                 Cited By 8
roj-2019-00010f1.jpgroj-2019-00010f2.jpgroj-2019-00010f3.jpg
Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?
Kyung Hwa Lee, Jeong Il Yu, Hee Chul Park, Su Yeon Park, Jung Suk Shin, Eun Hyuk Shin, Sungkoo Cho, Sang Hoon Jung, Young Yih Han, Do Hoon Lim
Radiat Oncol J. 2018;36(2):129-138.   Published online 2018 Jun 29     DOI: https://doi.org/10.3857/roj.2017.00598
                              Supplementary         Cited By 15
roj-2017-00598f1.jpgroj-2017-00598f2.jpgt3-roj-2017-00598.png
Clinical Investigations
Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
Hun Jung Kim, Jeong Hoon Phak, Woo Chul Kim
Radiat Oncol J. 2016;34(4):260-264.   Published online 2016 Jun 17     DOI: https://doi.org/10.3857/roj.2015.01571
                                 Cited By 8
roj-2015-01571f1.gifroj-2015-01571f2.gift1-roj-2015-01571.pngt2-roj-2015-01571.png
Physics Contribution
A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images
Sang Hoon Jung, Jeong Il Yu, Hee Chul Park, Do Hoon Lim, Youngyih Han
Radiat Oncol J. 2016;34(1):64-75.   Published online 2016 Mar 30     DOI: https://doi.org/10.3857/roj.2016.34.1.64
                                 Cited By 12
roj-34-64-g001.jpgroj-34-64-g002.jpgroj-34-64-g003.jpgroj-34-64-g004.jpgT1-roj-34-64.png
A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique
Antonio Pontoriero, Giuseppe Iatì, Stefano Pergolizzi
Radiat Oncol J. 2015;33(3):261-264.   Published online 2015 Sep 30     DOI: https://doi.org/10.3857/roj.2015.33.3.261
                                 Cited By 3
roj-33-261-g001.jpgroj-33-261-g002.jpg
Clinical Investigations
Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
Eonju Lee, Tae Gyu Kim, Hee Chul Park, Jeong Il Yu, Do Hoon Lim, Heerim Nam, Hyebin Lee, Joon Hyeok Lee
Radiat Oncol J. 2015;33(3):217-225.   Published online 2015 Sep 30     DOI: https://doi.org/10.3857/roj.2015.33.3.217
                                 Cited By 19
roj-33-217-g001.jpg
Stereotactic radiotherapy for early stage non-small cell lung cancer
Umberto Ricardi, Serena Badellino, Andrea Riccardo Filippi
Radiat Oncol J. 2015;33(2):57-65.   Published online 2015 Jun 30     DOI: https://doi.org/10.3857/roj.2015.33.2.57
                                 Cited By 28
roj-33-57-g001.jpg
Stereotactic body radiotherapy for solitary spine metastasis
Sunyoung Lee, Mison Chun, MiJo Lee
Radiat Oncol J. 2013;31(4):260-266.   Published online 2013 Dec 31     DOI: https://doi.org/10.3857/roj.2013.31.4.260
                                 Cited By 6
roj-31-260-g001.jpgroj-31-260-g002.jpgroj-31-260-g003.jpgroj-31-260-g004.jpg
Physics Contributions
Efficient approach for determining four-dimensional computed tomography-based internal target volume in stereotactic radiotherapy of lung cancer
Seung-Gu Yeo, Eun Seog Kim
Radiat Oncol J. 2013;31(4):247-251.   Published online 2013 Dec 31     DOI: https://doi.org/10.3857/roj.2013.31.4.247
                                 Cited By 17
roj-31-247-g001.jpg
1 |
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
HDX Corporation
Elekta Korea
Editorial Office
Department of Radiation Oncology, Seoul National University Hospital,
Hamchun Hall, 6F, 95 Daehak-ro, Jongno-gu, Seoul 03082, Republic of Korea
Tel : +82-2-743-6574
E-mail: roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next